JP Morgan Chase
MIST icon

JP Morgan Chase’s Milestone Pharmaceuticals MIST Stock Holding History

JP Morgan Chase’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3,266
Closed -$2.61K – 7428
2025
Q1 		$2.61K Buy
3,266
+2,366
+263% +$4.7K ﹤0.01% 6513
2024
Q4 		$2.12K Buy
+900
New +$1.54K ﹤0.01% 6633
2024
Q1 		– Sell
-10,662
Closed -$17.8K – 7699
2023
Q4 		$17.8K Sell
10,662
-233,694
-96% -$634K ﹤0.01% 6276
2023
Q3 		$758K Sell
244,356
-2,807
-1% -$8.72K ﹤0.01% 4256
2023
Q2 		$704K Sell
247,163
-128,891
-34% -$486K ﹤0.01% 4287
2023
Q1 		$1.48M Buy
376,054
+46,330
+14% +$169K ﹤0.01% 3756
2022
Q4 		$1.31M Buy
329,724
+276,049
+514% +$1.45M ﹤0.01% 3876
2022
Q3 		$493K Buy
53,675
+50,136
+1,417% +$380K ﹤0.01% 4477
2022
Q2 		$21K Sell
3,539
-10,041
-74% -$61.7K ﹤0.01% 5886
2022
Q1 		$87K Buy
13,580
+6,606
+95% +$41.3K ﹤0.01% 5576
2021
Q4 		$46K Buy
+6,974
New +$41.8K ﹤0.01% 5984
2020
Q4 		– Sell
-1,700
Closed -$13K – 5819
2020
Q3 		$13K Buy
+1,700
New +$12.2K ﹤0.01% 5224

Other funds holding MIST

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
AFA
Alta Fundamental Advisers New York $265M AUM 98.61% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase's MIST Position: Q2 2025 in Review

JP Morgan Chase sold out of Milestone Pharmaceuticals (MIST) in Q2 2025, closing a stake of 3,266 shares — an estimated $2.61K sold.

JP Morgan Chase first reported a position in MIST in Q3 2020 and held it in 12 quarters. The position peaked at $1.48M in Q1 2023. 43 funds tracked by Wall St. Rank hold MIST as of Q2 2025.

  • JP Morgan Chase reported no remaining Milestone Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • JP Morgan Chase sold 3,266 Milestone Pharmaceuticals shares in Q2 2025, an estimated $2.61K.
  • JP Morgan Chase first reported a position in Milestone Pharmaceuticals in Q3 2020 and held it in 12 quarters.
  • JP Morgan Chase's Milestone Pharmaceuticals position peaked at $1.48M in Q1 2023.
  • 43 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q2 2025.

Based on JP Morgan Chase's 13F filing for Q2 2025, filed 12 Aug 2025.